Daiichi Sankyo India Pharma Profile
Key Indicators
- Authorised Capital ₹ 178.00 Cr
as on 08-05-2024
- Paid Up Capital ₹ 177.00 Cr
as on 08-05-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2016
- Revenue 3.15%
(FY 2015)
- Profit 7.27%
(FY 2015)
- Ebitda -7.13%
(FY 2015)
- Net Worth 10.37%
(FY 2015)
- Total Assets 10.64%
(FY 2015)
About Daiichi Sankyo India Pharma
- CIN/LLPIN
U24233HR2007PTC044362
- Company No.
044362
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2007
- Date of AGM
28 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Daiichi Sankyo India Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Takashi Mochizuki  | Director | 01-Jul-2017 | Current |
Velloor Ranganathan  | Director | 01-Jul-2017 | Current |
| Masahiko Otsuki | Director | 12-Aug-2010 | Current |
Financial Performance and Corporate Structure Insights of Daiichi Sankyo India Pharma.
Daiichi Sankyo India Pharma Private Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 3.15% increase. The company also saw a slight improvement in profitability, with a 7.27% increase in profit. The company's net worth Soared by an impressive increase of 10.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daiichi Sankyo India Pharma?
In 2016, Daiichi Sankyo India Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bharti Axa Life Insurance Company LimitedActive 19 years 1 monthVelloor Ranganathan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Daiichi Sankyo India Pharma?
Unlock and access historical data on people associated with Daiichi Sankyo India Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daiichi Sankyo India Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daiichi Sankyo India Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
